HKSE - Delayed Quote HKD

Hospital Corporation of China Limited (3869.HK)

5.000 -3.800 (-43.18%)
At close: November 10 at 10:32 AM GMT+8
Key Events
Loading Chart for 3869.HK
DELL
  • Previous Close 8.800
  • Open 5.000
  • Bid --
  • Ask 7.800 x --
  • Day's Range 5.000 - 5.000
  • 52 Week Range 5.000 - 8.800
  • Volume 400
  • Avg. Volume 0
  • Market Cap (intraday) 685.575M
  • Beta (5Y Monthly) -0.13
  • PE Ratio (TTM) 21.74
  • EPS (TTM) 0.230
  • Earnings Date Mar 27, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Hospital Corporation of China Limited, an investment holding company, operates and manages hospitals in the People's Republic of China. The company operates through three segments: General Hospital Services; Hospital Management Services; and Sale of Pharmaceutical Products. The company provides inpatient and outpatient, management, supply chain, and other ancillary services to certain hospitals; and property management services. It engages in the wholesale of pharmaceutical products and medical consumables. The company was incorporated in 2014 and is headquartered in Beijing, the People's Republic of China. Hospital Corporation of China Limited is a subsidiary of Vanguard Glory Limited.

www.hcclhealthcare.com

1,457

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: 3869.HK

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

3869.HK
23.08%
HANG SENG INDEX
3.54%

1-Year Return

3869.HK
31.97%
HANG SENG INDEX
10.03%

3-Year Return

3869.HK
59.35%
HANG SENG INDEX
39.30%

5-Year Return

3869.HK
61.83%
HANG SENG INDEX
40.27%

Compare To: 3869.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 3869.HK

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    877.54M

  • Enterprise Value

    1.28B

  • Trailing P/E

    27.80

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.84

  • Price/Book (mrq)

    2.14

  • Enterprise Value/Revenue

    0.89

  • Enterprise Value/EBITDA

    4.50

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.20%

  • Return on Assets (ttm)

    8.75%

  • Return on Equity (ttm)

    32.54%

  • Revenue (ttm)

    1.43B

  • Net Income Avi to Common (ttm)

    131.38M

  • Diluted EPS (ttm)

    0.230

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    667.89M

  • Total Debt/Equity (mrq)

    174.10%

  • Levered Free Cash Flow (ttm)

    147.41M

Company Insights: 3869.HK